BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 22144466)

  • 1. The Hedgehog pathway promotes blood-brain barrier integrity and CNS immune quiescence.
    Alvarez JI; Dodelet-Devillers A; Kebir H; Ifergan I; Fabre PJ; Terouz S; Sabbagh M; Wosik K; Bourbonnière L; Bernard M; van Horssen J; de Vries HE; Charron F; Prat A
    Science; 2011 Dec; 334(6063):1727-31. PubMed ID: 22144466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of the kinin receptor B1 protects from autoimmune CNS disease by reducing leukocyte trafficking.
    Göbel K; Pankratz S; Schneider-Hohendorf T; Bittner S; Schuhmann MK; Langer HF; Stoll G; Wiendl H; Kleinschnitz C; Meuth SG
    J Autoimmun; 2011 Mar; 36(2):106-14. PubMed ID: 21216565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell trafficking competence is required for CNS invasion.
    Lees JR; Archambault AS; Russell JH
    J Neuroimmunol; 2006 Aug; 177(1-2):1-10. PubMed ID: 16822552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins reduce human blood-brain barrier permeability and restrict leukocyte migration: relevance to multiple sclerosis.
    Ifergan I; Wosik K; Cayrol R; Kébir H; Auger C; Bernard M; Bouthillier A; Moumdjian R; Duquette P; Prat A
    Ann Neurol; 2006 Jul; 60(1):45-55. PubMed ID: 16729291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inactivation of Hedgehog signal transduction in adult astrocytes results in region-specific blood-brain barrier defects.
    Wang H; Xu Z; Xia Z; Rallo M; Duffy A; Matise MP
    Proc Natl Acad Sci U S A; 2021 Aug; 118(34):. PubMed ID: 34417306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their involvement in G-protein-dependent lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis.
    Alt C; Laschinger M; Engelhardt B
    Eur J Immunol; 2002 Aug; 32(8):2133-44. PubMed ID: 12209625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.
    Correale J; Villa A
    Autoimmunity; 2007 Mar; 40(2):148-60. PubMed ID: 17453713
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Ninjurin-1 in the migration of myeloid cells to central nervous system inflammatory lesions.
    Ifergan I; Kebir H; Terouz S; Alvarez JI; Lécuyer MA; Gendron S; Bourbonnière L; Dunay IR; Bouthillier A; Moumdjian R; Fontana A; Haqqani A; Klopstein A; Prinz M; López-Vales R; Birchler T; Prat A
    Ann Neurol; 2011 Nov; 70(5):751-63. PubMed ID: 22162058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How do immune cells overcome the blood-brain barrier in multiple sclerosis?
    Larochelle C; Alvarez JI; Prat A
    FEBS Lett; 2011 Dec; 585(23):3770-80. PubMed ID: 21550344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preferential recruitment of interferon-gamma-expressing TH17 cells in multiple sclerosis.
    Kebir H; Ifergan I; Alvarez JI; Bernard M; Poirier J; Arbour N; Duquette P; Prat A
    Ann Neurol; 2009 Sep; 66(3):390-402. PubMed ID: 19810097
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro models of the blood-brain barrier.
    Czupalla CJ; Liebner S; Devraj K
    Methods Mol Biol; 2014; 1135():415-37. PubMed ID: 24510883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wip1 regulates blood-brain barrier function and neuro-inflammation induced by lipopolysaccharide via the sonic hedgehog signaling signaling pathway.
    Zhen H; Zhao L; Ling Z; Kuo L; Xue X; Feng J
    Mol Immunol; 2018 Jan; 93():31-37. PubMed ID: 29128669
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell surface levels of endothelial ICAM-1 influence the transcellular or paracellular T-cell diapedesis across the blood-brain barrier.
    Abadier M; Haghayegh Jahromi N; Cardoso Alves L; Boscacci R; Vestweber D; Barnum S; Deutsch U; Engelhardt B; Lyck R
    Eur J Immunol; 2015 Apr; 45(4):1043-58. PubMed ID: 25545837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activated leukocyte cell adhesion molecule promotes leukocyte trafficking into the central nervous system.
    Cayrol R; Wosik K; Berard JL; Dodelet-Devillers A; Ifergan I; Kebir H; Haqqani AS; Kreymborg K; Krug S; Moumdjian R; Bouthillier A; Becher B; Arbour N; David S; Stanimirovic D; Prat A
    Nat Immunol; 2008 Feb; 9(2):137-45. PubMed ID: 18157132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-9 promotes Th17 cell migration into the central nervous system via CC chemokine ligand-20 produced by astrocytes.
    Zhou Y; Sonobe Y; Akahori T; Jin S; Kawanokuchi J; Noda M; Iwakura Y; Mizuno T; Suzumura A
    J Immunol; 2011 Apr; 186(7):4415-21. PubMed ID: 21346235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelial Wnt/β-catenin signaling reduces immune cell infiltration in multiple sclerosis.
    Lengfeld JE; Lutz SE; Smith JR; Diaconu C; Scott C; Kofman SB; Choi C; Walsh CM; Raine CS; Agalliu I; Agalliu D
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):E1168-E1177. PubMed ID: 28137846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Blood-brain barrier genetic disruption leads to protective barrier formation at the Glia Limitans.
    Mora P; Hollier PL; Guimbal S; Abelanet A; Diop A; Cornuault L; Couffinhal T; Horng S; Gadeau AP; Renault MA; Chapouly C
    PLoS Biol; 2020 Nov; 18(11):e3000946. PubMed ID: 33253145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma cell adhesion molecule identifies encephalitogenic T lymphocytes and promotes their recruitment to the central nervous system.
    Larochelle C; Cayrol R; Kebir H; Alvarez JI; Lécuyer MA; Ifergan I; Viel É; Bourbonnière L; Beauseigle D; Terouz S; Hachehouche L; Gendron S; Poirier J; Jobin C; Duquette P; Flanagan K; Yednock T; Arbour N; Prat A
    Brain; 2012 Oct; 135(Pt 10):2906-24. PubMed ID: 22975388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential susceptibility of cerebral and cerebellar murine brain microvascular endothelial cells to loss of barrier properties in response to inflammatory stimuli.
    Silwedel C; Förster C
    J Neuroimmunol; 2006 Oct; 179(1-2):37-45. PubMed ID: 16884785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of the chemokine CCL2 on blood-brain barrier permeability during ischemia-reperfusion injury.
    Dimitrijevic OB; Stamatovic SM; Keep RF; Andjelkovic AV
    J Cereb Blood Flow Metab; 2006 Jun; 26(6):797-810. PubMed ID: 16192992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 39.